These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 4916538

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The clinical and metabolic effects of porcine calcitonin on Paget's disease of bone.
    Shai F, Baker RK, Wallach S.
    J Clin Invest; 1971 Sep; 50(9):1927-40. PubMed ID: 4935444
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Treatment of Paget's disease with salmon calcitonin].
    Manderlier T, Fuss M, Brauman J, Orloff S, Bergans A, Corvilain J.
    Rev Rhum Mal Osteoartic; 1977 Jan; 44(1):59-66. PubMed ID: 319520
    [No Abstract] [Full Text] [Related]

  • 5. [Influence of porcine calcitonin in 3 healthy patients and in a female patient with Paget's disease].
    Aznar Reig A, Zamora Madaria E, Herrera Justiniano E, Rubio Rubio JM, Gómez San Millán M, Merchante C.
    Rev Iber Endocrinol; 1971 Jan; 18(107):419-42. PubMed ID: 5133441
    [No Abstract] [Full Text] [Related]

  • 6. Metabolic effects of synthetic salmon calcitonin in Paget's disease of bone.
    Avramides A, Baker RK, Wallach S.
    Metabolism; 1974 Nov; 23(11):1037-46. PubMed ID: 4472557
    [No Abstract] [Full Text] [Related]

  • 7. Newer agents in treating Paget's disease of bone.
    Goldfield EB.
    Geriatrics; 1974 Dec; 29(12):61-9. PubMed ID: 4279196
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Metabolic balance studies in patients with Paget's disease receiving salmon calcitonin over long periods.
    Oreopoulos DG, Husdan H, Harrison J, Meema HE, McNeill KG, Murray TM, Ogilvie R, Rapoport A.
    Can Med Assoc J; 1977 Apr 23; 116(8):851-5. PubMed ID: 856428
    [Abstract] [Full Text] [Related]

  • 14. [Short-term biological effects of synthetic salmon calcitonin in Paget's disease. Influence of posology].
    Chapuy MC, Meunier P, Terrier M, David L, Vignon G.
    Pathol Biol (Paris); 1975 May 23; 23(5):349-59. PubMed ID: 172838
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Metabolic effects of calcitonin in man].
    Caniggia A, Gennari C.
    Minerva Med; 1973 May 23; 64(43):2249-58. PubMed ID: 4727514
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Combined diphosphonate and calcitonin therapy for Paget's disease of bone.
    Hosking DJ, Bijvoet OL.
    Calcif Tissue Res; 1976 Aug 23; 21 Suppl():321-6. PubMed ID: 821599
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.